Sign up to save your podcasts
Or
Share Thalidomide - The Reforms That Came Too Late and Still Aren't Enough
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Thalidomide - The Reforms That Came Too Late and Still Aren't Enough
Host Ava Grey examines post-thalidomide regulatory reforms that reshaped drug approval worldwide. Between 2001 and 2010, 71 FDA-approved drugs received severe safety warnings an average of four years after patients began taking them. She explores whether the promise of "never again" has been kept or repackaged.
Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV
This content was created in partnership and with the help of Artificial Intelligence AI.
View all episodes
By Inception Point AIHost Ava Grey examines post-thalidomide regulatory reforms that reshaped drug approval worldwide. Between 2001 and 2010, 71 FDA-approved drugs received severe safety warnings an average of four years after patients began taking them. She explores whether the promise of "never again" has been kept or repackaged.
Loved this episode? Discover more original shows from the Quiet Please Network at QuietPlease.ai, explore our curated favorites here amzn.to/42YoQGI, and catch just a slice of our AI hosts in action on Instagram at instagram.com/claredelish and YouTube at youtube.com/@DIYHOMEGARDENTV
This content was created in partnership and with the help of Artificial Intelligence AI.